ACHC

Acadia Healthcare Company, Inc. - 10-Q Summary (Q2 2026)

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2026. Acadia Healthcare Company, Inc. is a leading provider of behavioral healthcare services, operating 279 facilities with approximately 12,600 beds across 40 states and Puerto Rico. The company operates through acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers (CTCs), and residential treatment centers.

Key Financial Metrics

Material Changes vs. Prior Period

• Profitability Decline: Net income attributable to the company dropped significantly year-over-year (down 63.7% for Q2 and 61.0% YTD). This was driven by higher operating expenses and a sharp increase in the effective tax rate.
• Revenue Stability: Total revenue remained relatively flat in Q2 (-0.4%) but grew 3.3% YTD. Same-facility revenue grew 3.4% YTD, driven by a 6.5% increase in admissions, partially offset by a 5.0% decrease in average length of stay.
• Expense Increases:
  • Salaries, Wages, and Benefits: Increased to 54.8% of revenue in Q2 (from 52.0% in Q2 2025) due to wage inflation and equity-based compensation.
  • Legal and Liability Costs: A $28.6 million unfavorable actuarial adjustment was recorded for self-insured professional and general liability claims. Additionally, $13.8 million in legal settlements expense was recorded YTD related to the Sandoval Litigation.
  • Transaction Costs: Transaction, legal, and other costs decreased to $44.6 million YTD 2026 from $95.5 million YTD 2025, primarily due to lower government investigation costs in the current period.
• Impairment: Non-cash property impairment charges increased to $7.4 million YTD 2026 from $1.5 million YTD 2025.

Outlook, Risks, and Contingencies

• Government Investigations: The company is under active investigation by the DOJ Criminal Division and the SEC regarding admissions, length of stay, and billing practices. The company is cooperating but cannot estimate potential liabilities.
• Legal Proceedings:
  • Desert Hills Litigation: A sixth lawsuit was filed in 2024; the company cannot estimate liability.
  • Securities Litigation: A 2019 securities class action was settled for $179.0 million (with $31.5 million reimbursed by insurance). A new 2024 securities class action (Kachrodia) remains pending with an indeterminate liability.
  • Fashion Valley: A jury awarded $105.0 million in damages in an employment case; the company intends to appeal.
• Legislative Impact: The "One Big Beautiful Bill Act" (OBBBA) passed in July 2025 may reduce Medicaid expenditures and tighten eligibility, potentially impacting reimbursement rates and patient volumes starting in late 2026 and 2028.
• Liquidity: The company maintains a $1.0 billion revolving credit facility with $669.8 million available. The Consolidated Total Net Leverage Ratio was 4.1x at June 30, 2026, compliant with covenants.

Investor Verification Checklist

• Liability Reserves: Verify the adequacy of the $224.7 million professional and general liability reserve following the $28.6 million actuarial adjustment.
• Legal Exposure: Monitor the status of the DOJ/SEC investigations and the Fashion Valley appeal, as outcomes could result in material, uninsured losses.
• Reimbursement Rates: Assess the specific impact of the OBBBA on Medicaid reimbursement rates and eligibility requirements in key operating states.
• Operating Margins: Evaluate the sustainability of operating margins given the trend of rising labor costs (54.8% of revenue) and the reduction in average length of stay.
• Debt Service: Confirm the company's ability to service $2.41 billion in debt, particularly with interest rates on variable-rate debt (SOFR-based) remaining elevated.